Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

The world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

“He’s very happy to be coming back and very emotional about this," Sharon told The Sun. “Parkinson’s is a progressive disease ...

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...

Ozzy Osbourne is struggling to walk amid his battle with Parkinson’s disease — but his singing voice is “as good as ever,” ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...